NeuroTherapeutics Pharma Raises $43 Million
NeuroTherapeutics Pharma Inc., a Chicago-based developer of therapies for central nervous system (CNS) disorders, has raised $43 million in Series B funding. Fidelity Biosciences, MPM Capital and S.R. One Ltd. co-led the round, and were joined by Pfizer and return backers Novo Ventures and Thomas McNerney & Partners.
20 May 2010•3 mins read
